Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT00814372
PHASE2

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Sponsor: Gilead Sciences

View on ClinicalTrials.gov

Summary

To define the relative efficacy, safety and tolerability profiles of oral daily MBX-102 at daily doses of 400 and 600 mg vs. placebo and Actos® 30 mg (up-titrated to 45 mg after 8 weeks) when administered for up to 24 weeks in patients inadequately controlled with a stable dose of metformin (≥ 1500 mg/day).

Official title: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of MBX-102/JNJ-39659100 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

242

Start Date

2008-12

Completion Date

2010-02

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

DRUG

MBX-102

capsule

DRUG

Placebo

matching placebo

DRUG

Actos

over-encapsulated to match MBX-102 and placebo

DRUG

Metformin

greater than or equal to 1500 mg/kg day

Locations (26)

Providence Clinical Research

Burbank, California, United States

American Institute of Research

Los Angeles, California, United States

Nevada Alliance Against Diabetes

Las Vegas, Nevada, United States

Piedmont Medical Research Associates

Winston-Salem, North Carolina, United States

DGD Research, Inc.

San Antonio, Texas, United States

Kamineni Hospitals Pvt, Ltd.

Hyderabad, Andhra Pradesh, India

Bangalore Diabetes Centre

Bangalore, India

Diacon Hospital Diabetes & Research Centre

Bangalore, India

M. S. Ramaiah Memorial Hospital

Bangalore, India

St. John's Medical College & Hospital

Bangalore, India

Dr. V. Seshiah Diabetes Care & Research Institute

Chennai, India

Mediciti Hospital

Hyderabad, India

Medwin Hospital

Hyderabad, India

Diabetes Thyroid Hormone Research Institute Pvt. Ltd.

Indore, India

Fortis Hospital

Jaipur, India

Bharti Research Institute of Diabetes & Endocrinology

Karnāl, India

Amrita Institute of Medical Sciences

Kochi, India

Diabetes Action Centre

Mumbai, India

BYL Nair Hospital

Mumbai, India

PD Hindhuja National Hospital

Mumbai, India

Gandhi Endocrinology & Diabetes Centre

Nagpur, India

All India Institute of Medical Sciences

New Delhi, India

Deenanath Mangeshkar Hospital & Research Centre

Pune, India

Diabetes Care & Research Centre

Pune, India

Health & Research Centre

Trivendrum, India

Christian Medical College

Vellore, India